Hill-Rom Holdings (HRC) reported quarterly earnings results on Thursday, Aug-4-2016. The company said it had a profit of $0.81 Earnings per Share for the quarter. The results exceeded Wall Street expectations beating the analyst consensus estimate by $0.05. Analysts had a consensus of $0.76. The company posted revenue of $655.40 million in the period, compared to analysts expectations of $646.61 million. The company’s revenue was up 38.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.62 EPS.
Many Wall Street Analysts have commented on Hill-Rom Holdings. Hill-Rom Holdings was Upgraded by Morgan Stanley to ” Overweight” on Jun 16, 2016.
Hill-Rom Holdings closed down -0.18 points or -0.33% at $53.84 with 5,29,146 shares getting traded on Tusday. Post opening the session at $53.87, the shares hit an intraday low of $53.47 and an intraday high of $54.24 and the price fluctuated in this range throughout the day.Shares ended Tusday session in Red.
Investors should note that on Jul 20, 2016, Hill-Rom Holdings announced a cash dividend of $0.1700. The company’s management has announced Sep 14, 2016 as the ex-dividend date and fixed the record date on Sep 16, 2016. The payable date has been fixed on Sep 30, 2016.
In a different news, on May 17, 2016, Jason Richardson (VP, Controller & CAO) sold 2,952 shares at $47.80 per share price. According to the SEC, on Mar 16, 2015, Richard G Keller (VP, Controller & CAO) sold 4,996 shares at $48.42 per share price. On Feb 12, 2015, Alton Shader (Sr VP & Pres Post Acute Care) sold 15,253 shares at $46.30 per share price, according to the Form-4 filing with the securities and exchange commission.
Hill-Rom Holdings Inc. (Hill-Rom) is a medical technology company. The Company partners with health care providers in more than 100 countries by focusing on patient care solutions that improve clinical and economic outcomes in five core areas: Advancing Mobility Wound Care and Prevention Clinical Workflow Surgical Safety and Efficiency and Respiratory Health. The Company operates in three segments: North America Surgical and Respiratory Care and International. North America segment sells and rents its patient support and near-patient technologies and services as well as its clinical workflow solutions in the United States and Canada. Surgical and Respiratory Care segment sells and rents its surgical and respiratory care products globally. International segment sells and rents similar products as its North America segment in regions outside of the United States and Canada.